Verve Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $5.7M | 507k | 11.23 |
| 2024-12-31 | $4.5M | 799k | 5.62 |
| 2024-09-30 | $6.4M | 913k | 7.00 |
| 2024-06-30 | $3.0M | 624k | 4.86 |
| 2024-03-31 | $13M | 886k | 15.00 |
| 2023-12-31 | $8.7M | 347k | 25.00 |
| 2023-09-30 | $3.9M | 296k | 13.26 |
| 2023-06-30 | $6.4M | 342k | 18.80 |
| 2022-12-31 | $1.9M | 97k | 19.35 |
| 2022-06-30 | $3.7M | 198k | 18.52 |
| 2022-03-31 | $4.9M | 217k | 22.82 |
| 2021-06-30 | $149k | 2.5k | 60.37 |